1. The effect of infusion of noradrenaline (0.42pmolmin-' kg-I) on the exchange of nonesterified fatty acids, glycerol and other metabolites across subcutaneous abdominal adipose tissue was investigated in five healthy subjects using an arteriovenous catheterization technique and measurement of adipose tissue blood flow using the ' 33Xe clearance technique. At the same time, the net rate of fat oxidation in the whole body was assessed by indirect calorimetry, and the turnover of glycerol in the whole body and in subcutaneous adipose tissue was estimated using [I'H]glycerol, which was administered as a primed constant infusion for 1 h before (basal turnover) noradrenaline administration and continued during the 1 h of noradrenaline infusion. 2. The noradrenaline infusion increased the plasma noradrenaline concentration from a basal value of 0.9 f 0.1 to 12.6 f 1.2 nmol/( mean f SEM) at 60 min. It also increased the arterialized concentration of glycerol by 50% (basal value 81 f11 pmol/l-') and that of plasma non-esterified fatty acids three-fold (basal value 357 f 86 pmol/l). 3. Noradrenaline increased the net release of glycerol by adipose tissue three-fold and that of non-esterified fatty acids three-to four-fold. Although the ratio of non-esterified fatty acid to glycerol release by adipose tissue increased in all subjects from a mean value of 2.7 in the basal period to 3.6 and 3.9 at 50 and 60 min of the noradrenaline infusion, respectively
INTRODUCTION
In subjects leading a Western lifestyle, fat is the dominant source of energy after an overnight fast, and it becomes progressively more important as starvation progresses. Kinetic studies suggest that the amount of fatty acids made available from lipolysis exceeds the amount oxidized, since some fatty acids are recycled back to triacylglycerol (TAG) [l]. In order to understand the control of fatty acid metabolism it is necessary to consider the rates of lipolysis, oxidation and re-esterification of fatty acids. The rate of lipolysis has usually been assessed from measurements of the rate of appearance of non-esterified fatty acids (NEFA) or glycerol in plasma, with the assumption that NEFA and glycerol appear in a ratio close to 3:l. However, studies involving simultaneous turnover of glycerol and NEFA in resting humans after an overnight fast have produced variable ratios (appearance of NEFA/glycerol) in the whole body ranging from <3.0 [2-41, and as low as 1.0 [5] in a hyperinsulinaemic study, to 5.0 [6] . Values as high as [5] [6] [7] have been reported during recovery from exercise [6] , although this has not been confirmed in another study [3] . These widely differing results may partly relate to methodology and in some cases to the difficulties in interpreting results in a nonsteady-state. However, those workers that have obtained a ratio of < 3 have suggested that there is intracellular recycling of NEFA [2] and those authors that have obtained a particularly high ratio have argued that there may be partial hydrolysis of TAG in adipose tissue [7, 81 especially during augmented lipolysis, so that NEFA are released without accompanying glycerol.
In this study we used an arteriovenous catheterization technique across human subcutaneous abdominal adipose tissue to address three issues. First, the study aimed to examine the relationship between glycerol release and NEFA release before and after stimulation of lipolysis with noradrenaline (NA). The relationship could change during accelerated lipolysis, as it can after suppression of lipolysis [9] . Secondly, the study aimed to obtain further insight into the kinetics of glycerol metabolism in the whole body and in adipose tissue by infusing 'H-labelled glycerol and measuring its enrichment in arterialized blood and venous blood draining adipose tissue. Thirdly, the study aimed to assess the effect of NA on the metabolism of the whole body and adipose tissue by making measurements of gaseous exchange on the whole body and exchange of oxygen and various metabolites (glucose, lactate, pyruvate, ketone bodies, NEFA and TAG) across adipose tissue in vivo.
MATERIALS AND METHODS
Five healthy young male subjects of mean ( f SEM) weight 73.3 f 2.0 kg and height 177 f 2 cm (body mass index 23.6f0.05 kglm') were studied after an overnight fast. Their body composition was predicted from skinfold thicknesses, which were measured at four sites [lo], by bioelectrical resistance [ll] , and from the body mass index [12] . None of the subjects was a smoker and none took medication. They were weight-stable during the preceeding 3 months, while ingesting a typical Western diet which was not altered during the week preceeding the study. The subjects were considered to be neither sedentary nor particularly active.
Two venous cannulae were inserted: one on the dorsum of the hand for collecting arterialized blood (see below); and the other in an antecubital vein for infusion of radiolabelled glycerol and NA. The cannulae were kept patent by intermittent flushing with saline (0.9'2,NaCI). In addtion, a vein draining the subcutaneous adipose tissue of the anterior abdominal wall was cannulated, as described before [13] . A superficial vein on the anterior abdominal wall was cannulated in a downward direction, after which a Secalon Hydrocath catheter (22 gaugex 10 cm; Viggo Products, Swindon, Wilts, U.K.) was introduced over a guide wire, using the Seldinger technique. The tip was positioned so as to lie closely above the inguinal ligament as judged by surface anatomy. The catheter was kept patent with a slow infusion of saline.
After a 30min period of rest, radio-labelled glycerol ( [5-ZH]glycerol; Delta Isotopes, Crewe, Cheshire, U.K.) was infused at a rate of 1 pmolmin-I , kg-I body weight, after a priming bolus of lSprnol/kg body weight. After 60min of the radiolabelled glycerol infusion, NA was infused (0.42 nmol min ' kg I ) for a period of 60 min. The radiolabelled glycerol infusion was continued during the second hour when NA was infused.
Blood flow to the cannulated adipose tissue site was measured by the 'j3Xe clearance technique [14] .
133Xe dissolved in saline (Amersham International Ltd, Amersham, Bucks, U.K.) was injected into the subcutaneous adipose tissue. Approximately lOOpCi was injected slowly with a fine-bore needle to a depth of about 7mm. The radioactivity at the site was measured using sodium iodide crystal detectors placed at least lOcm away from the site. The counting of activity commenced at least 30min after the injection of '33Xe. Blood flow, which could be measured to within -4ml min-' 1OOg-1 adipose tissue, was calculated as the product of the rate constant of the decay curve and the partition coefficient of adipose tissue and expressed as flow min I lOOg-' tissue. For adipose tissue, the partition coefficient was taken to be 8.5ml/g (mean of 8.2 and 8.7ml/g obtained in two separate studies on samples of human subcutaneous adipose tissue [l5, 161).
Venous blood on the dorsum of the hand was arterialized using a hot-air box maintained at 68°C. The hand was kept in the box with the fingers loosely curled for at least 1&12min before blood sampling. Evidence of adequate arterialization was provided by the Hb saturation (95% and above being taken as adequate).
Blood samples from the adipose tissue drainage and from the dorsum of the hand (arterialized) were taken simultaneously at 0, + 50 and +60min after the start of the radiolabelled glycerol infusion, and at 30, 50 and 60min after the start of the NA infusion whilst radiolabelled glycerol continued to be infused. Further arterialized blood samples were taken at + 55 min during each of the 2 h.
The blood samples were placed in a lOml tube, which was anticoagulated with EDTA. Two millilitres of this sample were deproteinized with 4ml of ice-cold 3.574 (w/v) sulphosalicyclic acid and the supernatant was used for analysis of glycerol [17] . One aliquot of the anticoagulated blood was centrifuged and the plasma was stored with reduced gluNoradrenalineinduced lipolysir in human adipose tissue I 79 tathione (15mg/ml of plasma) at -80°C for subsequent catecholamine analysis. A further sample of blood (1 ml) was taken in a heparinized syringe for estimation of Hb and oxygen saturation by a haemoximeter (OSM-2; Radiometer, Copenhagen, Denmark). The blood samples for the measurement of glycerol enrichment were also deproteinized with 2 vols. of ice-cold 3.5% (w/v) sulphosalicyclic acid.
Glucose, lactate, pyruvate, alanine, acetoacetate, 3-hydroxybutyrate, glycerol [17] and NEFA (Kit 994-75409, WAKO Chemicals, GmBH, Japan), were measured by enzymic methods using the COBAS-BIO centrifugal analyser. Plasma TAG was also measured on the centrifugal analyser as the difference between plasma free glycerol [17] and total glycerol obtained after hydrolysis of TAG with lipase (Roche Diagnostic Kit 0710865). There was a linear relationship between change in absorbance and metabolite concentrations over the range examined.
[5-ZH]Glycerol enrichments in deproteinized whole blood were measured by g.c.-m.s. as described previously [ 181. Calibration curves of standard enriched with [5-2H] glycerol [O-20 atoms per cent excess (APE)] were generated daily and used to calculate sample enrichments. The mass measurements, which are specific to glycerol, were reproducible, with a coefficient of variation of -1% for samples enriched to the extent observed in this study.
Plasma insulin was measured by double-antibody radioimmunoassay, and plasma adrenaline and NA were measured by h.p.1.c. [19] . The blood haematocrit was measured by a microcapillary method.
Calculations
was calculated using the following formula:
The net flux of metabolites across adipose tissue Net exchange (nmol min-' 100ml-' tissue) =whole blood arteriovenous concentration difference (pmol/l) x blood flow (ml min-' 100g-' tissue)
In the case of substrates that are essentially restricted to plasma (TAG, NEFA) the concentration in whole blood was calculated first [whole blood concentration = plasma concentration x (1 -haematocrit)], before the above formula was used to estimate net exchange.
The apparent steady-state values of glycerol enrichments were used in the calculation of the rate of appearance of glycerol (R,) in the whole body. The formula used was [19a] : Indirect calorimetry was used to calculate the net rate of TAG oxidation in the whole body by methods described elsewhere [20] . In these calculations it was assumed that 15% of resting energy was due to protein oxidation. For values of protein oxidation of 10 and 20% the errors in the estimated fat oxidation would only be about k 6%.
Results are presented as means & SEM. Statistical analysis was carried out by analysis of variance for repeated measures and Student's paired t-test. The data for ketone bodies were logarithmically transformed before being subjected to statistical analysis.
The study was approved by the local ethics committee, and informed consent was obtained from the subjects.
RESULTS

Body composition
The total body fat in the subjects was estimated to be 15.6k 1.1 kg by anthropometry, 13.3k 1.1 kg by bioelectrical resistance and 14.9k0.8 kg by the body mass index formula. The mass of adipose tissue was calculated to be 16.4k 1.1 kg (mass 23% of body weight) using the body mass index formula and assuming that 88% body fat is in adipose tissue, and that adipose tissue contains 80% fat [21] .
Effect of NA on whole body gaseous exchange, acid-base status and cardiovascular parameters (Table I) NA increased oxygen consumption (mean 1 l%, P < 0.01) and decreased the respiratory exchange ratio by 0.04 (P <0.05) in all subjects, without significantly affecting acid-base status. There was a universal reduction in heart rate (mean 5 beats/min) and increase in blood pressure (Table 1) . (Table 2) NA produced a small but significant increase in blood glucose concentration (0.34.4 mmol/l), but the circulating concentrations of glycolytic products (lactate, pyruvate and alanine) were essentially unchanged. In contrast, the circulating concentrations of glycerol increased 1.5-fold [from a basal value of 8 2 k 13 (range 43-llO)pmol/l-', to 121 k 2 (range 69-175)pmol/l after 60min for NA] and those of NEFA three-to four-fold. Peak values were observed at + 30 min. Ketone bodies progressively rose during the NA infusion: 3-hydroxybutyrate rose six-fold (95 to 497 pmol/l) and acetoacetate two-fold (95 to 178pmol/l). TAG concentrations did not change significantly during the study.
Concentration of metabolites in arterialized blood
The concentration of NA increased more than ten-fold during the NA infusion, but that of adrenaline showed no increase. The circulating insulin concentration did not rise significantly despite the h ypergl ycaemia.
Concentration and enrichment of blood glycerol and plasma NEFA in arterialized and venous blood draining subcutaneous abdominal adipose tissue (Table 3) NA increased the arteriovenous concentration difference of glycerol and NEFA. The changes in these two metabolites paralleled each other. The maximum arteriovenous difference was at 30 min (cf. arterialized blood concentration).
An apparent near-steady-state was achieved in glycerol enrichment in arterialized blood after 50-60min of the glycerol infusion (basal state) and again after a further 50-60min when NA was infused. Thus, before the NA infusion, the values for glycerol enrichment at + 50 and + 60 rnin differed from the mean value (used in the calculations of R, for glycerol) by 0.12 f 0.19 APE, and during the NA infusion by -0.06 k0.07 APE. The corresponding values in venous blood draining adipose tissue were -0.00f0.06 and 0.09k0.04 APE. The range of enrichment of glycerol in venous blood was essentially distinct from that in arterialized blood. For example, after NA the individual values in arterialized blood ranged from 2.8 to 6.1 APE, and in venous blood draining subcutaneous abdominal adipose tissue, from 0.7 to 2.6 APE. The release of glycerol by adipose tissue was expected to decrease the glycerol enrichment in the venous blood draining adipose tissue, but the extent to which the enrichment decreased was significantly greater ( -40%) than that attributable to the net addition of glycerol to venous blood ( P < 0.01). Similarly, during the NA infusion, the measured glycerol enrichment in the venous blood was less than that predicted in all subjects, but the differences were variable and did not reach statistical significance.
Using the values of glycerol enrichment in arterialized blood, the estimated rate of appearance of glycerol in the whole body was estimated to be 1.5 f0.3 pmol min kg-in the basal period, and 2.6f0.3pmol min-' kg-' at the end of the NA infusion. The net rate of TAG oxidation in the whole body as calculated from indirect calorimetry was 1.2kO.l pmol min-' kg-l in the basal period and 1.7fO.lpmol rnin I kg I during the last 15min of the NA infusion. Isotopic estimates of R , for glycerol in the whole body when expressed in relation to adipose tissue mass were 640+ 120nmol min I 100 g adipose tissue before NA and 1 150 f I40 nmol min ~ I 100 g ' adipose tissue after NA.
The value before NA was almost two-fold higher than the net release of glycerol from adipose tissue (339 f 72 nmol min-I 100 g -I tissue).
Blood flow and net exchange of metabolites across adipose tissue (Table 4)
Blood flow to adipose tissue remained steady during the basal period (mean values of 2.8, 2.5 and 2.4 ml rnin -100 g-' tissue, at 0, 30 and 5&60 min, respectively). NA increased the basal adipose tissue blood flow (range 1.5-4.2ml min-' IOOg-' tissue) two-to three-fold (range 4.5-7.4ml min-' 100g-l tissue). NA produced no significant changes in the net flux (exchange) of oxygen, glucose, lactate, pyruvate and alanine, although the uptake of glucose and release of lactate tended to increase at +30min of the NA infusion. The increase in blood flow produced by NA reduced the arteriovenous concentration differences of some of the metabolites making it difficult to obtain an accurate estimate of the difference (e.g. 0.1 mmol for glucose at 60min). In (pmol min-' kg-' body weight) (based on body composition and assuming abdominal adipose tissue is typical of the whole adipose tissue mass) was related to the R , for glycerol in the whole body (pmol min-' kg-', r=0.85).
DISCUSSION
General effects of NA This study confirms some of the well-known general effects of NA, including an increase in metabolic rate, a reduction in heart rate and changes in the circulating concentration of various metabolites. The largest percentage increase in metabolite concentrations in arterialized blood involved NEFA (three-to five-fold) and ketone bodies (two-to six-fold), which are derived from NEFA. Since fatty acids are an important determinant of net fat oxidation in the whole body [22] , it is not surprising that the respiratory exchange ratio was significantly decreased at the end of the NA infusion. The circulating glucose concentration also increased, but the percentage change (5-!00/,) was smaller than for NEFA. The increase in glucose concentration is probably partly the result of competition between NEFA and glucose in peripheral tissues (glucose-fatty acid cycle), and the inhibitory effect of NA on insulin secretion [23] . Therefore the circulating insulin concentration failed to show a rise, despite hyperglycaemia.
Net exchange of metabolites across adipose tissue
This study provides the most direct demonstration so far on the effect of NA in increasing lipolysis in human adipose tissue in vivo. In the basal state the ratio of NEFA to glycerol release was 2.7, which is close to and not significantly different from the theoretical value of 3.0, which assumes that all the NEFA and glycerol produced from the hydrolysis of TAG in adipose tissue is released. Therefore there would be little NEFA recycling in the basal state (a best estimate of -10% re-esteritication), confirming the results of another study of arteriovenous exchange of glycerol and NEFA which was carried out after an overnight fast [24] . However, in the present study measurements at 50-60min after NA administration, when a near-steady-state existed (the 30 min measurements are more difficult to interpret due to greater uncertainty about the steady-state), gave a universal increase in the ratio of NEFA to glycerol release. At least four theoretical possibilities exist. The first is that any basal NEFA re-esterification (implied by a NEFA to glycerol release ratio of <3.0) is reduced. The second is that NEFA are released without accompanying glycerol. This could happen if there was either incomplete hydrolysis of TAG so that monoacylglycerol (MAG) and/or diacylglycerol (DAG) accumulated in adipose tissue, or glycerol recycling (glycerokinase).
Studies in v i m have shown that partially hydrolysed TAG may accumulate in adipose tissue during increased lipolysis. Under normal circumstances, about 0.1% [25] to 0.5% of the lipid in human adipose tissue [26] exists as DAG (160-920pmol/ l00g of lipid) but the concentration may increase by 50% when lipolysis is stimulated [27] . If this occurred in our study in oioo during the NA infusion, the extent of MAG or DAG accumulation that is necessary to explain our observations would be small. If during the NA infusion 0-600nmol of NEFA min-' 1OOg-' adipose tissue was released in excess of the theoretical rate of three times the glycerol release (Table 4) , the total excess NEFA released during the 1 h of the infusion is 0-36pmol. This means that during the 1 h study period the total NEFA is equivalent to the production of 0- The third theoretical explanation of an increase in the ratio of NEFA to glycerol release after NA is that there may be re-utilization and oxidation of glycerol (rather than re-esterification). This is not considered to be a likely explanation because the activity of glycerokinase in adipose tissue is low. From the activity of glycerokinase in human adipose tissue biopsies it is estimated that the utilization of glycerol is only about 1% of its rate of production [28] . Furthermore, measurement of the amount of radiolabelled glycerol incorporated into TAG is very small (-0.1%) in comparison with the net amount of glycerol released by human adipocytes in v i m [27] , which suggests that the reutilization of glycerol occurs at a low rate.
The fourth possibility is that there may be changes in the pool of free glycerol or NEFA in adipose tissue during the period of measurement, so that the amount produced does not necessarily equal the amount released. The importance of pool size is again considered below in relation to the tracer studies.
The source of energy for the metabolic processes in adipose tissue remains uncertain [24] . Both glucose and NEFA could be important. However, the amount of ketone bodies taken up by adipose tissue after NA, could account for more than half of the oxygen consumption of adipose tissue (assuming complete oxidation of acetoacetate (4 mol of OJmol) and 3-hydroxybutyrate (4.5 mol of O,/mol).
R, for glycerol
Although there was a relationship between whole body R , for glycerol and net adipose tissue glycerol release, the isotopic values expressed in relation to lOOg of adipose tissue (assuming that 88% of the body fat is in adipose tissue and that adipose tissue consists of 80% fat [21]) are two-fold higher than the observed values of the net rate of glycerol released by subcutaneous abdominal adipose tissue in the basal state. There are at least three possible explanations for this apparent discrepancy. The first is that there may be substantial differences in the lipolytic activity of adipose tissue at different sites [29- 311. The second is that some glycerol may appear in tissues other than adipose tissue. Many tissues contain lipoprotein lipase, which is situated on vascular endothelial cells or intracellular hormone-sensitive lipases, which contribute to R, for glycerol. In addition, substantial TAG-fatty acid recycling may occur within individual tissues, especially liver [32] , and contribute to the R, for glycerol if there is isotopic exchange between plasma glycerol and intrahepatic glycerol. The third possibility is that the tracer technique might overestimate the R, of glycerol. To understand this it is necessary to consider the enrichment of glycerol in the blood supplying and draining adipose tissue.
There was a three-to five-fold increase in glycerol enrichment between arterialized and venous blood draining adipose tissue (Table 3) which cannot entirely be explained by the net addition of unlabelled glycerol. This is because the observed enrichment of glycerol in the venous blood was universally lower than that predicted from the net addition of glycerol to venous blood. This means that there must be exchange between enriched glycerol in the blood and the unenriched free glycerol pool in adipose tissue. If it is assumed that the free glycerol pool is entirely restricted to the water present in adipose tissue [ -15% (w/w) in reference man [21] ], and the concentration of glycerol in this space is the same as that in the venous blood draining adipose tissue, then it can be calculated that in the brisal period there is -12 pmol of glyceroI/lOOg of adipose tissue. In order to assess whether during the basal period sufficient time had elapsed for the free glycerol pool in the adipose tissue to fully equilibrate with enriched glycerol in the venous blood ( -230 pmol/l and 1.6 APE) it is necessary to estimate the total amount of glycerol supplied to adipose tissue via arterial blood during the same time. Since the glycerol concentration was -80pmol/l (see Table 3 ) and the basal blood flow to adipose tissue was -2.5ml min-' IOOg-' tissue, then the total amount of glycerol entering adipose tissue over 1 h is 12pmol. If this glycerol (12pmol) with an enrichment of -8.5 APE (see Table 3 ) freely and instantaneously equilibrated with both the free glycerol in adipose tissue ( -12 pmol) and that released by lOOg of adipose tissue into venous blood over 1 h (net amount -2Opmo1, see Table 4 ), the combined enrichment of glycerol in both the venous blood and the adipose tissue pool should be about {[12/(12+ 12+20)] x8.5}, or 2.3 APE, which is less than the value of 2.7-2.9 APE predicted from the dilution of glycerol by the net amount released into the venous blood (Table 3 ). This suggests that the glycerol infusion may not have been administered for a sufficiently long period of time to achieve a steady-state, although this is the typical time used by various authors to assess glycerol turnover using labelled and unlabelled glycerol infusions with or without a priming dose [l, 2, 33-40] . A slow blood flow and a large free glycerol pool in adipose tissue would cause a delay in the time taken to achieve full equilibration. During the NA infusion, increased blood flow would tend to reduce the time taken for equilibration, whilst an increase in the free glycerol pool resulting from increased lipolysis would delay it. An implication of the above is that the tracer estimation of the R , for glycerol as an index of lipolysis in the whole body may have been overestimated both before and after NA. Isotopic estimates of R, for glycerol across adipose tissue, calculated by the procedure suggested by Spitzer (411 suggest universal overestimation relative to the net release estimated enzymically (339 f 72 versus 242 & 64 pmol min-' 1OOg-' before NA, P<O.Ol; and 1291&295 versus 1021 k211 pmol min-' 1OOg-' after NA; not significant). Even larger percentage discrepancies have been reported across muscle [ 181.
According to the above line of argument, the enrichment of glycerol in venous blood will be expected to rise with time to a value close to that predicted from the net release of unenriched glycerol (Table 3 ) and reduce the apparent glycerol turnover in the whole body. The studies of Bortz et al. [42] who carried out 8 h long ['4C]glycerol infusions are unable to clarify further this issue because of the large variability in results, which are due to the limitations of the techniques used.
In conclusion, this study demonstrates that infused NA increases blood flow to adipose tissue and increases the rate and ratio of NEFA glycerol release. It also demonstrates a discrepancy between R, for glycerol in adipose tissue assessed by an isotopic technique and the net release of glycerol, which may be explained by the presence of a pool of free glycerol in adipose tissue. Finally, it also demonstrates a discrepancy between the R, for glycerol in the whole body (expressed per kg adipose tissue) and net release of glycerol by subcutaneous abdominal adipose tissue, which may be explained by regional differences in adipose tissue lipolysis, and by metabolism of glycerol in tissues other than adipose tissue.
